Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

November 16, 2025 updated by: Sanliurfa Education and Research Hospital

Evaluation of Neurosonographic Findings in Pregnant Women With Vitamin D Deficiency

In the study, the potential effects of vitamin D deficiency on fetal neurodevelopmental parameters will be examined. In this context, fetal brain development will be compared between pregnant women with and without vitamin D deficiency, revealing the possible neurodevelopmental outcomes of vitamin D deficiency during the prenatal period.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Vitamin D is a vitamin that regulates calcium and phosphorus balance in the body and plays a crucial role in bone health. Additionally, it is known to have effects on immune system functions and neurological health. Pregnancy is a period in which vitamin D requirements increase, and vitamin D deficiency can lead to various health problems. It is believed that vitamin D deficiency may have adverse effects on fetal neurological development and may be associated with certain pathological conditions during pregnancy.

Neurosonography is a critical tool for assessing the effects of prematurity, vitamin D deficiency, and other pregnancy complications on the fetus. This article will focus on the evaluation of neurosonographic findings in pregnant women with vitamin D deficiency.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Sanliurfa, Turkey (Türkiye), 63100
        • Sanliurfa Education and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients presenting to the Perinatology clinic of Şanlıurfa Training and Research Hospital for routine antenatal care between 20-30 weeks of gestation will be included.

Description

Inclusion Criteria:Patients presenting for routine antenatal care between 20-30 weeks of gestation will be included.

Exclusion Criteria:Multiple pregnancy, preterm rupture of membranes, chorioamnionitis, placental abruption, severe fetal growth restriction, congenital fetal anomalies, preeclampsia, oligohydramnios and maternal diabetes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks
Other: Neurosonographic Findings of Vitamin D Deficiency in Single Healthy Pregnancies Presenting for Routine Antenatal Care Between 20-30 Weeks of Gestation.
Comparison of Neurosonographic Findings in Patients with and without Vitamin D Deficiency.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Pregnant women with vitamin D deficiency who present for routine antenatal care between 20-30 weeks of gestation.
Time Frame: Neurosonogram Results Performed Between 20-30 Weeks of Gestation.
Neurosonogram Results Performed Between 20-30 Weeks of Gestation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sanliurfa Education and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2025

Primary Completion (Actual)

June 30, 2025

Study Completion (Estimated)

November 30, 2025

Study Registration Dates

First Submitted

March 24, 2025

First Submitted That Met QC Criteria

March 24, 2025

First Posted (Actual)

March 30, 2025

Study Record Updates

Last Update Posted (Actual)

November 18, 2025

Last Update Submitted That Met QC Criteria

November 16, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ŞEAH-DVİT-NORO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neurosonographic Findings of Vitamin D Deficiency

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe